Polar Capital Holdings »

Bridgebio Pharma shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-12-31 $8.9M 8.5M 1.05
2024-09-30 $13M 13M 1.03

More positions owned by Polar Capital Holdings

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Microsoft Corporation Call Option (MSFT)
Cloudflare Cl A Com (NET)
Lam Research Corp Com New (LRCX)
Kla Corp Com New (KLAC)
Seagate Technology Hldngs Pl Ord Shs (STX)
Renaissance Re Holdings Ltd Cmn (RNR)
Apple (AAPL)
Corning Incorporated (GLW)
Arch Cap Group Ord (ACGL)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Credo Technology Group Holdi Ordinary Shares (CRDO)

View all positions for Polar Capital Holdings

Top funds holding Bridgebio Pharma

Linden Advisors
Weiss Asset Management LP[1
Wolverine Asset Management
Tenor Capital Management
Citadel Advisors
Graham Capital Management
Balyasny Asset Management
Ing Investment Management
Capstone Investment Advisors
Lazard Asset Management
683 Capital Management
Lord, Abbett & Co
M&G
State Street Corporation
Millennium Management

View all funds holding Bridgebio Pharma